Pharmerica (PMC) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PharMerica Reports First Quarter 2016 Results
May 6, 2016 8:01 AM EDTFinancial Results Exceed Expectations
Strong Cash Flow From Operating Activities
Industry Leading Generic Dispensing Rate Increases to Record 86.6%
Reaffirms Annual 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the first quarter ended March 31, 2016.
             1Q16 Results  ÂComparison to 1Q15
 ÂComparison to 4Q15
Revenue   $524.5 million   Increase of 2.5%   Increase of 0.7%... More